Sorafenib Tosylate API Market, Global Outlook and Forecast 2025-2032

Ajouter une nouvelle offre d'emploi Autre

2025-01-13 11:26:26 -

Report Overview Sorafenib Tosylate is an active pharmaceutical ingredient (API) that is used in the treatment of certain types of cancer, including advanced renal cell carcinoma and hepatocellular carcinoma. It works by blocking the action of enzymes and proteins that are involved in cancer cell growth and division. Download FREE Sample of this Report...

0 Commentaires 0 Parts 22 Vue 0 Aperçu